66746 Results

People

  1. Brennan
    Brennan
  2. Gonen
    Gonen
  3. Vickers
    Vickers
  4. Ladanyi
    Ladanyi
  5. Scher
    Scher
  6. Motzer
    Motzer
  7. Reuter
    Reuter
  8. Jarnagin
    Jarnagin
  9. Fong
    Fong
  10. Antonescu
    Antonescu

Groups

  1. Department of Medicine (19346)
  2. GSK Faculty (13834)
  3. Surgery (13274)
  4. Sloan Kettering Institute Faculty (11206)
  5. Solid Tumor Oncology Division (10830)
  6. Survivorship Research (8899)
  7. Sloan Kettering Institute Postdocs (7820)
  8. Population Sciences Research Program (7144)
  9. Department of Pathology and Laboratory Medicine (6438)
  10. Epidemiology and Biostatistics (6429)
  1. "Journal article"
Formats
  1. Journal Article (66746)
Groups
  1. Department of Medicine (19346)
  2. GSK Faculty (13834)
  3. Surgery (13274)
  4. Sloan Kettering Institute Faculty (11206)
  5. Solid Tumor Oncology Division (10830)
  6. Survivorship Research (8899)

More Groups

People
  1. Murray Brennan (769)
  2. Mithat Gonen (757)
  3. Andrew Vickers (683)
  4. Marc Ladanyi (647)
  5. Howard Scher (624)
  6. Robert Motzer (609)

More People

Years
  1. 2025 (1026)
  2. 2024 (2329)
  3. 2023 (2318)
  4. 2022 (2449)
  5. 2021 (2507)
  6. 2020 (2337)

More Years

Publications
  1. Journal of Clinical Oncology (2143)
  2. Cancer (1294)
  3. Clinical Cancer Research (1174)
  4. Proceedings of the National Academy of Sciences of the United States of America (985)
  5. Blood (938)
  6. Annals of Surgical Oncology (885)

More Publications

Publishers
  1. Elsevier Inc. (7387)
  2. Springer (4153)
  3. Elsevier Science, Inc. (3901)
  4. Lippincott Williams & Wilkins (3828)
  5. Nature Publishing Group (3746)
  6. Wiley Blackwell (3486)

More Publishers

Results (66746)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Patient-reported receipt of oncology clinician-delivered brief tobacco treatment (5As) six months following cancer diagnosis
    Journal Article

    Price, S. N.; Neil, J. M.; Flores, M.; Ponzani, C.; Muzikansky, A.; Ballini, L.; Ostroff, J. S.; Park, E. R.
    Oncology (2023)

    Fulltext@MSK | Save
  • Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): A multicentre, randomised, double-blind, phase 3 trial
    Journal Article

    Shitara, K.; Lordick, F.; Bang, Y. J.; Enzinger, P.; Ilson, D.; Shah, M. A.; Van Cutsem, E.; Xu, R. H.; Aprile, G.; Xu, J.; more...
    Lancet (2023)

    Fulltext@MSK | Save
  • Clinicopathologic and genomic factors impacting efficacy of first-line chemoimmunotherapy in advanced NSCLC
    Journal Article

    Alessi, J. V.; Elkrief, A.; Ricciuti, B.; Wang, X.; Cortellini, A.; Vaz, V. R.; Lamberti, G.; Frias, R. L.; Venkatraman, D.; Fulgenzi, C. A. M.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Using social media to recruit individuals for health-related research: Feasibility and lessons learned
    Journal Article

    Walsh, L. E.; Carter-Bawa, L.
    Journal of Health Psychology (2023)

    Fulltext@MSK | Save
  • ANCHOR CRC: Results from a single-arm, phase II study of encorafenib plus binimetinib and cetuximab in previously untreated BRAF(V600E)-mutant metastatic colorectal cancer
    Journal Article

    Van Cutsem, E.; Taieb, J.; Yaeger, R.; Yoshino, T.; Grothey, A.; Maiello, E.; Elez, E.; Dekervel, J.; Ross, P.; Ruiz-Casado, A.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Lenvatinib plus pembrolizumab in previously treated advanced endometrial cancer: Updated efficacy and safety from the randomized phase III study 309/KEYNOTE-775
    Journal Article

    Makker, V.; Colombo, N.; Herráez, A. C.; Monk, B. J.; Mackay, H.; Santin, A. D.; Miller, D. S.; Moore, R. G.; Baron-Hay, S.; Ray-Coquard, I.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Tarlatamab, a first-in-class DLL3-targeted bispecific T-cell engager, in recurrent small-cell lung cancer: An open-label, phase I study
    Journal Article

    Paz-Ares, L.; Champiat, S.; Lai, W. V.; Izumi, H.; Govindan, R.; Boyer, M.; Hummel, H. D.; Borghaei, H.; Johnson, M. L.; Steeghs, N.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Integrating tobacco treatment into oncology care: Reach and effectiveness of evidence-based tobacco treatment across national cancer institute–designated cancer centers
    Journal Article

    Hohl, S. D.; Matulewicz, R. S.; Salloum, R. G.; Ostroff, J. S.; Baker, T. B.; Schnoll, R.; Warren, G.; Bernstein, S. L.; Minion, M.; Lenhoff, K.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Does expectancy affect insomnia treatment response in cancer survivors receiving acupuncture and cognitive behavioral therapy?
    Journal Article

    Li, X.; Bao, T.; Garland, S. N.; Li, S. Q.; Yu, J.; Li, Y.; Mao, J. J.
    Journal of Cancer Survivorship (2023)

    Fulltext@MSK | Save
  • Long-term update of NRG/RTOG 0522: A randomized phase 3 trial of concurrent radiation and cisplatin with or without cetuximab in locoregionally advanced head and neck cancer
    Journal Article

    Caudell, J. J.; Torres-Saavedra, P. A.; Rosenthal, D. I.; Axelrod, R. S.; Nguyen-Tan, P. F.; Sherman, E. J.; Weber, R. S.; Galvin, J. M.; El-Naggar, A. K.; Konski, A. A.; more...
    International Journal of Radiation Oncology, Biology, Physics (2023)

    Fulltext@MSK | Save